Market Cap 1.33B
Revenue (ttm) 270.26M
Net Income (ttm) 14.08M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE 72.39
Profit Margin 5.21%
Debt to Equity Ratio 0.00
Volume 482,300
Avg Vol 365,190
Day's Range N/A - N/A
Shares Out 72.20M
Stochastic %K 26%
Beta 0.29
Analysts Strong Sell
Price Target $35.83

Latest News on KNSA

Kiniksa Pharmaceuticals Provides Corporate Update

Jan 4, 2024, 7:30 AM EST - 1 year ago

Kiniksa Pharmaceuticals Provides Corporate Update


Kiniksa Pharmaceuticals: Arcalyst's Growth Picks Up

Jul 27, 2023, 10:57 AM EDT - 1 year ago

Kiniksa Pharmaceuticals: Arcalyst's Growth Picks Up


Kiniksa Pharmaceuticals: A Somewhat Complicated Story

Jun 9, 2023, 12:32 PM EDT - 1 year ago

Kiniksa Pharmaceuticals: A Somewhat Complicated Story